Search

Search Constraints

You searched for: Author/Creator Rix, Uwe

Search Results

2. Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition. Issue 1 (23rd November 2017)

3. Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets. Issue 9 (19th September 2019)

5. Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. Issue 1 (5th November 2013)

6. Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Issue 12 (22nd December 2016)

7. Targeting a cell state common to triple‐negative breast cancers. Issue 2 (19th February 2015)

8. The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors. Issue 2 (17th February 2022)